Mazor G - Search Results

1

Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes.

Musa J, Cidre-Aranaz F, Aynaud MM, Orth MF, Knott MML, Mirabeau O, Mazor G, Varon M, Hölting TLB, Grossetête S, Gartlgruber M, Surdez D, Gerke JS, Ohmura S, Marchetto A, Dallmayer M, Baldauf MC, Stein S, Sannino G, Li J, Romero-Pérez L, Westermann F, Hartmann W, Dirksen U, Gymrek M, Anderson ND, Shlien A, Rotblat B, Kirchner T, Delattre O, Grünewald TGP. Musa J, et al. Among authors: mazor g. Nat Commun. 2019 Sep 11;10(1):4128. doi: 10.1038/s41467-019-12071-2. Nat Commun. 2019. PMID: 31511524 Free PMC article.

2

The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.

Mazor G, Levin L, Picard D, Ahmadov U, Carén H, Borkhardt A, Reifenberger G, Leprivier G, Remke M, Rotblat B. Mazor G, et al. Cell Death Dis. 2019 Mar 13;10(3):246. doi: 10.1038/s41419-019-1477-5. Cell Death Dis. 2019. PMID: 30867410 Free PMC article.

3

The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.

Varon M, Levy T, Mazor G, Ben David H, Marciano R, Krelin Y, Prasad M, Elkabets M, Pauck D, Ahmadov U, Picard D, Qin N, Borkhardt A, Reifenberger G, Leprivier G, Remke M, Rotblat B. Varon M, et al. Among authors: mazor g. Int J Cancer. 2019 Dec 15;145(12):3402-3413. doi: 10.1002/ijc.32400. Epub 2019 Jun 12. Int J Cancer. 2019. PMID: 31081944 Free article.

4

TP73-AS1 is induced by YY1 during TMZ treatment and highly expressed in the aging brain.

Mazor G, Smirnov D, Ben David H, Khrameeva E, Toiber D, Rotblat B. Mazor G, et al. Aging (Albany NY). 2021 Jun 11;13(11):14843-14861. doi: 10.18632/aging.203182. Epub 2021 Jun 11. Aging (Albany NY). 2021. PMID: 34115613 Free PMC article.

5

Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience.

Rouvinov K, Mazor G, Kozlener E, Meirovitz A, Shrem NS, Abu Saleh O, Shalata S, Yakobson A, Shalata W. Rouvinov K, et al. Among authors: mazor g. J Pers Med. 2023 Nov 20;13(11):1623. doi: 10.3390/jpm13111623. J Pers Med. 2023. PMID: 38003938 Free PMC article.

6

HYDRA: Hybrid deep magnetic resonance fingerprinting.

Song P, Eldar YC, Mazor G, Rodrigues MRD. Song P, et al. Among authors: mazor g. Med Phys. 2019 Nov;46(11):4951-4969. doi: 10.1002/mp.13727. Epub 2019 Sep 10. Med Phys. 2019. PMID: 31329307

7

Low-rank magnetic resonance fingerprinting.

Mazor G, Weizman L, Tal A, Eldar YC. Mazor G, et al. Med Phys. 2018 Jul 4. doi: 10.1002/mp.13078. Online ahead of print. Med Phys. 2018. PMID: 29972693

8

Low rank magnetic resonance fingerprinting.

Mazor G, Weizman L, Tal A, Eldar YC. Mazor G, et al. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:439-442. doi: 10.1109/EMBC.2016.7590734. Annu Int Conf IEEE Eng Med Biol Soc. 2016. PMID: 28268366

9

Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9.

Barel O, Shalev SA, Ofir R, Cohen A, Zlotogora J, Shorer Z, Mazor G, Finer G, Khateeb S, Zilberberg N, Birk OS. Barel O, et al. Among authors: mazor g. Am J Hum Genet. 2008 Aug;83(2):193-9. doi: 10.1016/j.ajhg.2008.07.010. Am J Hum Genet. 2008. PMID: 18678320 Free PMC article.

10

Hereditary hypotonia, muscle weakness, failure to thrive, and cognitive delay in a large moslem kindred.

Kutai M, Shalev SA, Chervinski I, Mazor G, Rabie M, Nevo Y. Kutai M, et al. Among authors: mazor g. Pediatr Neurol. 2006 Dec;35(6):425-9. doi: 10.1016/j.pediatrneurol.2006.06.017. Pediatr Neurol. 2006. PMID: 17138013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page